Lv1
30 积分 2024-02-18 加入
Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials
2个月前
已完结
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
3个月前
已完结
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
3个月前
已完结
Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
3个月前
已完结
The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy
4个月前
已完结
Molecular mechanisms and therapeutic targets for diabetic kidney disease
4个月前
已完结
The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a Bayesian network meta-analysis of 58 randomized controlled trials
4个月前
已关闭
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
4个月前
已完结
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition
4个月前
已完结
Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease
4个月前
已完结
皖公网安备34019202002308
